Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Han, C.-S.
* Articles by Kim, Y.-K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Han, C.-S.
* Articles by Kim, Y.-K.
Related Collections
* Delirium
Psychosomatics 45:297-301, August 2004
© 2004 The Academy of Psychosomatic Medicine

A Double-Blind Trial of Risperidone and Haloperidol for the Treatment of Delirium

Chang-Su Han, M.D., Ph.D., and Yong-Ku Kim, M.D., Ph.D.

Received March 10, 2003; revision received Aug. 20, 2003; accepted Aug. 30, 2003. From the Department of Psychiatry, College of Medicine, Korea University Ansan Hospital. Address correspondence to Dr. Kim, Director and Associate Professor, Department of Psychiatry, Korea University, College of Medicine, Ansan Hospital, Ansan City, Gojan Dong, 516, Kyunggi Province, 425-020, Korea; yongku{at}korea.ac.kr (e-mail).

To compare the clinical efficacy of haloperidol and risperidone for the treatment of delirium, the authors performed a double-blind comparative study. Twenty-eight patients with delirium were recruited and randomly assigned to receive a flexible-dose regimen of haloperidol or risperidone over 7 days. The severity of delirium was assessed by using Memorial Delirium Assessment Scale scores. Scores for each group decreased significantly over the study period. However, no significant differences in mean Memorial Delirium Assessment Scale scores between groups were found. The group-by-time effect was not significant. In addition, there was no significant difference in the frequency of response to the drugs between the two groups. One patient in the haloperidol group experienced mild akathisia, but no other patients reported clinically significant side effects. These data show no significant difference in the efficacy or response rate between haloperidol and risperidone in the treatment of delirium.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
G. L. Fricchione, S. H. Nejad, J. A. Esses, T. J. Cummings Jr., J. Querques, N. H. Cassem, and G. B. Murray
Postoperative Delirium
Am J Psychiatry, July 1, 2008; 165(7): 803 - 812.
[Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
B. Laible and T. Johnson
Delirium in the Hospitalized Patient: A Primer for the Pharmacist Clinician
Journal of Pharmacy Practice, October 1, 2007; 20(5): 368 - 372.
[Abstract] [PDF]


Home page
PsychosomaticsHome page
N. S. Karnik, S. V. Joshi, C. Paterno, and R. Shaw
Subtypes of Pediatric Delirium: A Treatment Algorithm
Psychosomatics, June 1, 2007; 48(3): 253 - 257.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
H. Lacasse, M. M Perreault, and D. R Williamson
Systematic Review of Antipsychotics for the Treatment of Hospital-Associated Delirium in Medically or Surgically Ill Patients
Ann. Pharmacother., November 1, 2006; 40(11): 1966 - 1973.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
D. A. Straker, P. A. Shapiro, and P. R. Muskin
Aripiprazole in the Treatment of Delirium
Psychosomatics, October 1, 2006; 47(5): 385 - 391.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org